Evidence map›Paper›PMID 29039492›Full record

ArticleInternational journal of molecular medicine2017

Black rice-derived anthocyanins inhibit HER-2-positive breast cancer epithelial-mesenchymal transition-mediated metastasis in vitro by suppressing FAK signaling.

Jie Zhou, Yan-Feng Zhu, Xiang-Yan Chen, Bin Han, Fei Li, Jing-Yao Chen, Xiao-Li Peng, Li-Ping Luo, Wei Chen, Xiao-Ping Yu

Open access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Dark Sweet Cherry (Molecules (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Network Pharmacology Analysis, Molecular Docking, andEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  14. Expression of 34The Journal of international medical research · 2021
    Article
  15. Review
  16. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jie ZhouDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Yan-Feng ZhuDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Xiang-Yan ChenDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Bin HanDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Fei LiDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Jing-Yao ChenDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Xiao-Li PengDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Li-Ping LuoDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Wei ChenDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Xiao-Ping YuDepartment of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China.
Chengdu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the role of focal adhesion kinase (FAK) signaling in the inhibitory effects of black rice anthocyanins (BRACs) on human epidermal growth factor receptor-2 (HER-2)-positive human breast cancer cell metastasis, using the MCF-10A, MCF-7 and MDA-MB-453 cells. BRACs exerted an anti-metastatic effect on the HER-2-positive breast cancer cells. The effects of BRACs on the proliferation of the MDA-MB-453 cells were examined by cell counting kit-8 assay. A wound-healing assay was used to examine the effects of BRACs on the migration of the breast cancer cells. BRACs interrupted migration and invasion. BRACs decreased the migration distance of the HER-2-positive human breast cancer cells, MDA-MB-453, by 37% compared with the cells in the untreated group. They also reduced the number of invading MDA-MB-453 cells by 68%. In addition, BRACs exerted an inhibitory effect on epithelial-mesenchymal transition. Western blot analysis revealed that BRACs decreased the phosphorylation of FAK, cSrc and p130Cas. The FAK inhibitor, Y15, was also used to further evaluate the role of FAK signaling in the anti-metastatic effects of BRACs on MDA-MB-453 cells. The results of western blot analysis revealed that BRACs increased the expression of the epithelial marker, E-cadherin, and decreased the expression of the mesenchymal markers, fibronectin and vimentin, in the MDA-MB‑453 cells. In addition, BRACs decreased the interaction between HER-2 and FAK, FAK and cSrc, cSrc and p130Cas, and between FAK and p130Cas. These results suggest that BRACs suppress the metastasis of HER-2-positive breast cancer in vitro, and that the cSrc/FAK/p130Cas pathway plays a vital role in this inhibitory effect.

Indexed as

AnthocyaninsAntineoplastic AgentsBreast NeoplasmsCell Line, TumorEpithelial-Mesenchymal TransitionErb-b2 Receptor Tyrosine KinasesFemaleFocal Adhesion Protein-Tyrosine KinasesFocal AdhesionsHumansOryzaPlant ExtractsSignal TransductionAnthocyaninsAntineoplastic AgentsERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesFocal Adhesion Protein-Tyrosine KinasesPlant Extracts

Identifiers

PMID29039492
PMCPMC5716451
OpenAlexW2763444562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.